Intracardiac thrombosis and embolism in patients with cardiac amyloidosis

Circulation

Volumn 116, Issue 21, 2007, Pages 2420-2426

  Feng, DaLi ^a,b   Edwards, William D ^b   Oh, Jae K ^b   Chandrasekaran, Krishnaswamy ^b   Grogan, Martha ^b   Martinez, Matthew W ^a,b   Syed, Imran I ^a,b   Hughes, Deborah A ^a,b   Lust, John A ^b   Jaffe, Allan S ^b   Gertz, Morie A ^b   Klarich, Kyle W ^b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Amyloid; Arrhythmia; Diastole; Echocardiography; Thrombosis

Indexed keywords

ADULT; AGED; ARTICLE; AUTOPSY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONFIDENCE INTERVAL; CONTROLLED STUDY; FATALITY; FEMALE; HEALTH CENTER; HEART AMYLOIDOSIS; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FAILURE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INTRACARDIAC THROMBOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SCREENING; STATISTICAL SIGNIFICANCE; THROMBOEMBOLISM; THROMBUS;

ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; DATABASES, FACTUAL; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; REGISTRIES; THROMBOEMBOLISM;

EID: 36349011376     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.697763     Document Type: Article

References (35)

1. Kyle RA, Linos A, Beard CM, Linke RP, Gertz MA, O'Fallon WM, Kurland LT. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood. 1992;79:1817-1822.
2. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997;337:898-909.
3. Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005;112:2047-2060.
4. Roberts WC, Waller BF. Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients. Am J Cardiol. 1983;52:137-146.
5. Skinner M, Anderson J, Simms R, Falk R, Wang M, Libbey C, Jones LA, Cohen AS. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med. 1996;100:290-298.
6. Kyle RA, Greipp PR. Amyloidosis (AL): clinical and laboratory features in 229 cases. Mayo Clin Proc. 1983;58:665-683.
7. Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine. 2003;82:291-298.
8. Chamarthi B, Dubrey SW, Cha K, Skinner M, Falk RH. Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis. Am J Cardiol. 1997;80:1242-1245.
9. Botker HE, Rasmussen OB. Recurrent cerebral embolism in cardiac amyloidosis. Int J Cardiol. 1986;13:81-83.
10. Browne RS, Schneiderman H, Kayani N, Radford MJ, Hager WD. Amyloid heart disease manifested by systemic arterial thromboemboli. Chest. 1992;102:304-307.
11. Santarone M, Corrado G, Tagliagambe LM, Manzillo GF, Tadeo G, Spata M, Longhi M. Atrial thrombosis in cardiac amyloidosis: diagnostic contribution of transesophageal echocardiography. J Am Soc Echocardiogr. 1999;12:533-536.
12. Cools FJ, Kockx MM, Boeckxstaens GE, Heuvel PV, Cuykens JJ. Primary systemic amyloidosis complicated by massive thrombosis. Chest. 1996;110:282-284.
13. Oh JK. The Echo Manual. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2006.
14. Willens HJ, Levy R, Kessler KM. Thromboembolic complications in cardiac amyloidosis detected by transesophageal echocardiography. Am Heart J. 1995;129:405-406.
15. Santarone M, Corrado G, Tagliagambe LM. Images in cardiology: biatrial thrombosis in cardiac amyloidosis. Heart. 1999;81:302.
16. Dubrey S, Pollak A, Skinner M, Falk RH. Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Br Heart J. 1995;74:541-544.
17. Halligan CS, Lacy MQ, Vincent Rajkumar S, Dispenzieri A, Witzig TE, Lust JA, Fonseca R, Gertz MA, Kyle RA, Pruthi RK. Natural history of thromboembolism in AL amyloidosis. Amyloid. 2006;13:31-36.
18. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials [published correction appears in Arch Intern Med. 1994;154:2254]. Arch Intern Med. 1994;154:1449-1457.
19. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, I: clinical features of patients at risk. Ann Intern Med. 1992;116:1-5.
20. Klein AL, Hatle LK, Burstow DJ, Taliercio CP, Seward JB, Kyle RA, Bailey KR, Gertz MA, Tajik AJ. Comprehensive Doppler assessment of right ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol. 1990;15:99-108.
21. Vaziri SM, Larson MG, Lauer MS, Benjamin EJ, Levy D. Influence of blood pressure on left atrial size: the Framingham Heart Study. Hypertension. 1995;25:1155-1160.
22. Modesto KM, Dispenzieri A, Cauduro SA, Lacy M, Khandheria BK, Pellikka PA, Belohlavek M, Seward JB, Kyle R, Tajik AJ, Gertz M, Abraham TP. Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques. Eur Heart J. 2005;26:173-179.
23. Berghoff M, Kathpal M, Khan F, Skinner M, Falk R, Freeman R. Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis. Ann Neurol. 2003;53:725-730.
24. Inoue H, Saito I, Nakazawa R, Mukaida N, Matsushima K, Azuma N, Suzuki M, Miyasaka N. Expression of inflammatory cytokines and adhesion molecules in haemodialysis-associated amyloidosis. Nephrol Dial Transplant. 1995;10:2077-2082.
25. Yood RA, Skinner M, Rubinow A, Talarico L, Cohen AS. Bleeding manifestations in 100 patients with amyloidosis. JAMA. 1983;249:1322-1324.
26. Plehn JF, Southworth J, Cornwell GG III. Brief report: atrial systolic failure in primary amyloidosis. N Engl J Med. 1992;327:1570-1573.
27. Klein AL, Hatle LK, Burstow DJ, Seward JB, Kyle RA, Bailey KR, Luscher TF, Gertz MA, Tajik AJ. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol. 1989;13:1017-1026.
28. Liao R, Jain M, Teller P, Connors LH, Ngoy S, Skinner M, Falk RH, Apstein CS. Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts. Circulation. 2001;104:1594-1597.
29. Murphy L, Falk RH. Left atrial kinetic energy in AL amyloidosis: can it detect early dysfunction? Am J Cardiol. 2000;86:244-246.
30. Stables RH, Ormerod OJ. Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Heart. 1996;75:426.
31. Dubrey S, Mendes L, Skinner M, Falk RH. Resolution of heart failure in patients with AL amyloidosis. Ann Intern Med. 1996;125:481-484.
32. Brenner DA, Jain M, Pimentel DR, Wang B, Connors LH, Skinner M, Apstein CS, Liao R. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res. 2004;94:1008-1010.
33. Dispenzieri A, Kyle RA, Lacy MQ, Therneau TM, Larson DR, Plevak MF, Rajkumar SV, Fonseca R, Greipp PR, Witzig TE, Lust JA, Zeldenrust SR, Snow DS, Hayman SR, Litzow MR, Gastineau DA, Tefferi A, Inwards DJ, Micallef IN, Ansell SM, Porrata LF, Elliott MA, Gertz MA. Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study. Blood. 2004;103:3960-3963.
34. Dubrey SW, Burke MM, Hawkins PN, Banner NR. Cardiac transplantation for amyloid heart disease: the United Kingdom experience. J Heart Lung Transplant. 2004;23:1142-1153.
35. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349:583-596.